David Wallace
Deputy Editor
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From David Wallace
Oxytetracycline Prices Double As Hydrocortisone Plunges In UK
July saw UK generic trade price rises peak at a 100% increase for oxytetracycline 250mg tablets, while hydrocortisone 20mg tablets saw their average price plummet by two-thirds, according to the latest figures from WaveData.
Dr Reddy's Is Knocked Back On US NuvaRing And Copaxone Rivals
Dr Reddy’s has received a further CRL from the US Food and Drug Administration over its application for a generic rival to Merck Sharp & Dohme’s NuvaRing contraceptive, along with a CRL for its version of Teva’s Copaxone.
Perrigo Remains Committed To Splitting Off Prescription Despite Delay
Perrigo has pushed back plans to split off its Prescription business as part of its transformation into a consumer self-care focused company.
US Appeals Court Denies Genentech Injunction Over Amgen's 'At Risk' Trastuzumab Launch
Genentech has been denied its request for a US injunction against Amgen over its at-risk launch of a trastuzumab biosimilar rival to Herceptin.
China’s Nanjing King-Friend Takes Control Of US Injectables Specialist Meitheal
China’s Nanjing King-Friend Biochemical Pharmaceutical has taken a majority stake in US generic injectables specialist Meitheal Pharmaceuticals.
Two Weeks Remain To Enter Industry Awards
Firms now have until 23 August to enter the Global Generics & Biosimilars Awards 2019.